KORU Medical Systems, Inc. (KRMD)
USD 2.32
(1.75%)
USD 2.32
(1.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.46 Million USD | -32.77% |
| 2022 | 42.33 Million USD | 2.52% |
| 2021 | 41.29 Million USD | 3.44% |
| 2020 | 39.91 Million USD | 187.56% |
| 2019 | 13.88 Million USD | 31.64% |
| 2018 | 10.54 Million USD | 13.62% |
| 2017 | 9.28 Million USD | 13.59% |
| 2016 | 8.17 Million USD | -2.67% |
| 2015 | 8.39 Million USD | 15.29% |
| 2014 | 7.28 Million USD | 17.27% |
| 2013 | 6.2 Million USD | 11.02% |
| 2012 | 5.59 Million USD | 16.38% |
| 2011 | 4.8 Million USD | 39.9% |
| 2010 | 3.43 Million USD | 14.96% |
| 2009 | 2.98 Million USD | 29.31% |
| 2008 | 2.31 Million USD | 77.04% |
| 2007 | 1.3 Million USD | 14.63% |
| 2006 | 1.13 Million USD | 24.15% |
| 2005 | 916.98 Thousand USD | -6.46% |
| 2004 | 980.27 Thousand USD | -17.5% |
| 2003 | 1.18 Million USD | 6.98% |
| 2002 | 1.11 Million USD | -20.62% |
| 2001 | 1.39 Million USD | -3.07% |
| 2000 | 1.44 Million USD | -8.33% |
| 1999 | 1.57 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 27.3 Million USD | -0.72% |
| 2024 Q1 | 27.5 Million USD | -3.37% |
| 2023 Q1 | 38.25 Million USD | -9.63% |
| 2023 Q3 | 35.35 Million USD | -1.78% |
| 2023 Q2 | 35.99 Million USD | -5.9% |
| 2023 FY | 28.46 Million USD | -32.77% |
| 2023 Q4 | 28.46 Million USD | -19.5% |
| 2022 Q3 | 42.66 Million USD | 0.48% |
| 2022 FY | 42.33 Million USD | 2.52% |
| 2022 Q4 | 42.33 Million USD | -0.78% |
| 2022 Q1 | 43.42 Million USD | 5.17% |
| 2022 Q2 | 42.46 Million USD | -2.23% |
| 2021 Q1 | 42.37 Million USD | 6.15% |
| 2021 Q2 | 40.59 Million USD | -4.19% |
| 2021 Q4 | 41.29 Million USD | -0.16% |
| 2021 Q3 | 41.35 Million USD | 1.87% |
| 2021 FY | 41.29 Million USD | 3.44% |
| 2020 Q3 | 45.43 Million USD | -4.77% |
| 2020 Q2 | 47.71 Million USD | 187.36% |
| 2020 Q4 | 39.91 Million USD | -12.14% |
| 2020 FY | 39.91 Million USD | 187.56% |
| 2020 Q1 | 16.6 Million USD | 19.6% |
| 2019 Q1 | 11.56 Million USD | 9.66% |
| 2019 Q3 | 13.71 Million USD | 16.73% |
| 2019 Q4 | 13.88 Million USD | 1.2% |
| 2019 FY | 13.88 Million USD | 31.64% |
| 2019 Q2 | 11.75 Million USD | 1.62% |
| 2018 Q1 | 9.36 Million USD | 0.86% |
| 2018 FY | 10.54 Million USD | 13.62% |
| 2018 Q2 | 10.25 Million USD | 9.6% |
| 2018 Q4 | 10.54 Million USD | -0.3% |
| 2018 Q3 | 10.57 Million USD | 3.11% |
| 2017 Q2 | 8 Million USD | -2.03% |
| 2017 Q1 | 8.17 Million USD | -3.59% |
| 2017 FY | 9.28 Million USD | 13.59% |
| 2017 Q4 | 9.28 Million USD | 8.03% |
| 2017 Q3 | 8.59 Million USD | 7.33% |
| 2016 Q2 | 8.33 Million USD | -0.71% |
| 2016 FY | 8.17 Million USD | -2.67% |
| 2016 Q3 | 8.34 Million USD | 0.1% |
| 2016 Q1 | 8.39 Million USD | 2.45% |
| 2016 Q4 | 8.47 Million USD | 1.58% |
| 2015 Q2 | 7.42 Million USD | 2.02% |
| 2015 Q1 | 7.28 Million USD | -1.43% |
| 2015 Q4 | 8.19 Million USD | 6.27% |
| 2015 Q3 | 7.71 Million USD | 3.8% |
| 2015 FY | 8.39 Million USD | 15.29% |
| 2014 Q3 | 7.09 Million USD | 6.33% |
| 2014 Q4 | 7.38 Million USD | 4.14% |
| 2014 Q2 | 6.67 Million USD | 7.45% |
| 2014 FY | 7.28 Million USD | 17.27% |
| 2014 Q1 | 6.2 Million USD | 10.99% |
| 2013 FY | 6.2 Million USD | 11.02% |
| 2013 Q4 | 5.59 Million USD | 3.04% |
| 2013 Q3 | 5.42 Million USD | 3.39% |
| 2013 Q2 | 5.25 Million USD | -6.1% |
| 2013 Q1 | 5.59 Million USD | 3.53% |
| 2012 Q1 | 4.8 Million USD | 7.94% |
| 2012 Q3 | 5.21 Million USD | 8.45% |
| 2012 FY | 5.59 Million USD | 16.38% |
| 2012 Q2 | 4.8 Million USD | -0.0% |
| 2012 Q4 | 5.4 Million USD | 3.65% |
| 2011 Q4 | 4.45 Million USD | 7.16% |
| 2011 FY | 4.8 Million USD | 39.9% |
| 2011 Q2 | 3.73 Million USD | 8.75% |
| 2011 Q1 | 3.43 Million USD | 11.38% |
| 2011 Q3 | 4.15 Million USD | 11.22% |
| 2010 Q1 | 2.98 Million USD | 24.97% |
| 2010 FY | 3.43 Million USD | 14.96% |
| 2010 Q4 | 3.08 Million USD | 6.01% |
| 2010 Q3 | 2.9 Million USD | -3.33% |
| 2010 Q2 | 3 Million USD | 0.72% |
| 2009 Q3 | 2.31 Million USD | 3.4% |
| 2009 Q4 | 2.39 Million USD | 3.43% |
| 2009 FY | 2.98 Million USD | 29.31% |
| 2009 Q1 | 2.31 Million USD | 38.46% |
| 2009 Q2 | 2.23 Million USD | -3.25% |
| 2008 Q3 | 1.47 Million USD | 8.21% |
| 2008 FY | 2.31 Million USD | 77.04% |
| 2008 Q4 | 1.66 Million USD | 12.8% |
| 2008 Q2 | 1.36 Million USD | 4.76% |
| 2008 Q1 | 1.3 Million USD | 10.59% |
| 2007 FY | 1.3 Million USD | 14.63% |
| 2007 Q4 | 1.18 Million USD | 3.55% |
| 2007 Q3 | 1.13 Million USD | 9.69% |
| 2007 Q2 | 1.03 Million USD | -8.74% |
| 2007 Q1 | 1.13 Million USD | 11.65% |
| 2006 Q4 | 1.01 Million USD | -2.42% |
| 2006 Q1 | 916.98 Thousand USD | -1.23% |
| 2006 FY | 1.13 Million USD | 24.15% |
| 2006 Q2 | 832.9 Thousand USD | -9.17% |
| 2006 Q3 | 1.04 Million USD | 25.45% |
| 2005 Q3 | 904.69 Thousand USD | -0.5% |
| 2005 Q2 | 909.2 Thousand USD | -7.25% |
| 2005 Q1 | 980.27 Thousand USD | -3.22% |
| 2005 Q4 | 928.42 Thousand USD | 2.62% |
| 2005 FY | 916.98 Thousand USD | -6.46% |
| 2004 Q2 | 1.23 Million USD | 3.92% |
| 2004 Q1 | 1.18 Million USD | 17.0% |
| 2004 FY | 980.27 Thousand USD | -17.5% |
| 2004 Q4 | 1.01 Million USD | -10.24% |
| 2004 Q3 | 1.12 Million USD | -8.61% |
| 2003 Q2 | 1.09 Million USD | -0.96% |
| 2003 Q1 | 1.11 Million USD | -14.86% |
| 2003 Q4 | 1.01 Million USD | -8.23% |
| 2003 Q3 | 1.1 Million USD | 0.61% |
| 2003 FY | 1.18 Million USD | 6.98% |
| 2002 Q1 | 1.39 Million USD | -3.0% |
| 2002 Q2 | 1.37 Million USD | -1.98% |
| 2002 Q3 | 1.34 Million USD | -1.95% |
| 2002 Q4 | 1.3 Million USD | -2.99% |
| 2002 FY | 1.11 Million USD | -20.62% |
| 2001 Q2 | 1.5 Million USD | 4.24% |
| 2001 Q3 | 1.48 Million USD | -1.54% |
| 2001 Q4 | 1.44 Million USD | -2.64% |
| 2001 Q1 | 1.44 Million USD | -4.38% |
| 2001 FY | 1.39 Million USD | -3.07% |
| 2000 Q4 | 1.5 Million USD | -1.41% |
| 2000 FY | 1.44 Million USD | -8.33% |
| 2000 Q2 | 1.62 Million USD | 0.0% |
| 2000 Q3 | 1.53 Million USD | -5.59% |
| 1999 FY | 1.57 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 84.221% |
| AngioDynamics, Inc. | 317.67 Million USD | 91.041% |
| AtriCure, Inc. | 613.93 Million USD | 95.364% |
| Avinger, Inc. | 13.77 Million USD | -106.688% |
| Azenta, Inc. | 2.88 Billion USD | 99.014% |
| BioLife Solutions, Inc. | 412.71 Million USD | 93.104% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.756% |
| Daxor Corporation | 34.86 Million USD | 18.378% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 1.58% |
| Femasys Inc. | 27.75 Million USD | -2.541% |
| GlucoTrack, Inc. | 4.9 Million USD | -480.244% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 79.281% |
| Hologic, Inc. | 9.15 Billion USD | 99.689% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.35% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.816% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 91.793% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -357.663% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -357.663% |
| Masimo Corporation | 3.04 Billion USD | 99.064% |
| Microbot Medical Inc. | 8.32 Million USD | -241.791% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 83.445% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 98.776% |
| Nephros, Inc. | 11.86 Million USD | -139.954% |
| NovoCure Limited | 1.14 Billion USD | 97.517% |
| NEXGEL, Inc. | 9.95 Million USD | -185.896% |
| NEXGEL, Inc. | 9.95 Million USD | -185.896% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 89.279% |
| OraSure Technologies, Inc. | 482.84 Million USD | 94.106% |
| Pro-Dex, Inc. | 54.21 Million USD | 47.499% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 53.192% |
| Predictive Oncology Inc. | 14.41 Million USD | -97.409% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -68.283% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.668% |
| Repligen Corporation | 2.82 Billion USD | 98.992% |
| Sanara MedTech Inc. | 73.87 Million USD | 61.472% |
| STAAR Surgical Company | 488.69 Million USD | 94.176% |
| Sharps Technology, Inc. | 11.78 Million USD | -141.414% |
| Utah Medical Products, Inc. | 135.45 Million USD | 78.989% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.614% |
| Jin Medical International Ltd. | 32.9 Million USD | 13.502% |